Preliminary studies on in vivo refolding of TRAIL inclusion bodies

Ya-Nan TANG,Ruo-Jun PAN,Jin-Song ZHOU,Guo-jun Zhang,Jing SUN,Yi QIU,Dong-Zhi WEI,Ya-Ling SHEN
DOI: https://doi.org/10.3969/j.issn.1001-6678.2009.04.007
2009-01-01
Abstract:TRAIL as a novel anticancer therapeutic agent in development, however, is prone to aggregate into inclusion bodies when expressed in recombinant Escherichia coli. The applicability of in vivo refolding of inclusion bodies was well evaluated. The results showed that after induction, the yield of soluble TRAIL was significantly enhanced to 16.7% when cultivated further at 30 ℃ for 4 h, prior to arrest of protein synthesis by chloramphenicol addition (up to 50 μg/mL). It was confirmed successfully in 3.7 L fermentor for producing 14.5% soluble TRAIL.
What problem does this paper attempt to address?